Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice - Wikidata - wikimedia - TriplyDB

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

http://www.wikidata.org/entity/Q35747037

about

Clinical immunologic approaches for the treatment of Alzheimer's disease Vaccination Strategies for Alzheimer???s Disease CD4 T cells in immunity and immunotherapy of Alzheimer's disease Sex and Immunogen-Specific Benefits of Immunotherapy Targeting Islet Amyloid Polypeptide in Transgenic and Wild-Type Mice Immunotherapeutic approaches for Alzheimer's disease Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine.Amyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleeds.Amyloid-beta immunotherapy for Alzheimer's disease Novel immunological approaches for the treatment of Alzheimer's disease.Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease.Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.Immunization treatment approaches in Alzheimer's and prion diseases.Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.Immunological approaches as therapy for Alzheimer's disease.Alzheimer vaccine: amyloid-beta on trial.Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model Lessons from the analysis of nonhuman primates for understanding human aging and neurodegenerative diseases Does my mouse have Alzheimer's disease?Wheat germ agglutinin enhanced cerebral uptake of anti-Aβ antibody after intranasal administration in 5XFAD mice Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages Immunization delays the onset of prion disease in mice.Clearing amyloid through the blood-brain barrier.Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer's Disease Like Tau Aggregation.Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain.Immunological and anti-chaperone therapeutic approaches for Alzheimer disease.Neurovascular pathways and Alzheimer amyloid beta-peptide.Refining an Alzheimer's vaccine to avoid an inflammatory response.Immunization therapy in Alzheimer's disease.Developing novel immunogens for an effective, safe Alzheimer's disease vaccine.Drug Insight: emerging therapies for amyloidosis.Memantine in the treatment of mild-to-moderate Alzheimer's disease.Current experimental therapy for Alzheimer's disease

P2860

Q22241380-F341A117-4111-43C3-9003-851736C3FC78 Q22241439-721F70EB-5041-47A4-9A74-0C03A7607524 Q27024202-CCEF81BE-6C3F-4F0C-9937-4FFF86475E56 Q27329865-093F12F9-ADD9-4E9C-8DD3-1608FE4E4C7C Q28081278-B365700C-1D76-4A12-A07F-0B351D0DABB4 Q29615839-4B8B443B-26A1-4433-8E79-B325E51FBF03 Q33248701-977BBD7C-9C2B-4A0A-9A61-13714E1EED0E Q33742312-0DE3F9C4-360E-4E13-AF71-54BAA25EA199 Q33935251-EE6EB924-6BA0-4F67-BD8A-9E5455E688A8 Q33954737-F6FA5A73-2DED-4F45-9F7E-BE6AA867C1E7 Q34562675-2D2637F1-7144-41ED-A04E-22BCF171AA49 Q34611770-62988EAA-30D0-4501-A4DB-B79B08DB66F4 Q34687112-E11D4040-C9AE-45A7-ABD7-459DA8D01D0D Q34698382-68B686C4-053C-4CC7-8243-31B865B72295 Q34721350-53A66B66-FBE6-46D2-9495-1D620AC280CD Q34760606-FEB8E4D6-87BB-414D-A50E-FEA94866966B Q34763076-D53D5E8D-110E-4C54-A6D9-60059C0F8973 Q34778095-C7072D63-F75C-4EC8-A54A-6CD58E97B71A Q34960461-A3854C70-A4E0-42AA-96CF-7CDE70BBD81C Q35040852-F49CC41F-F885-4283-8889-43888AF76B62 Q35069720-1437DDAC-0185-471E-BC15-12AB79E5E6DF Q35102897-16F3E5B0-FDD1-4B0E-86A2-A9856F43AF98 Q35103136-501661F8-EFDB-4FA7-A9DF-0347217B6DA1 Q35104249-2821D95F-D5A6-498E-B8A8-DC39E4A6B994 Q35145776-D1F836A3-86E1-4A57-B14C-C51ED16F2573 Q35186500-DB3B4A85-641C-4ED4-9C7A-AF490E9CA54F Q35300928-9C2383FB-A8D5-4BFD-BA3D-E2F7C731B1B9 Q35606537-5E15C55C-0AAD-4354-BE72-590C2BFC8F18 Q35747479-B0EE286B-215C-45F6-B5D5-9AE4751CDDC9 Q35771708-5A80C351-6938-48C0-8047-82445236A6E5 Q35826638-EB75E88D-8DC2-4786-ABBF-CAA76EA440D4 Q36005623-E19BB41B-A6C7-41FE-9ACB-8A18CBBE7335 Q36075474-D4016877-CB62-44F6-9D83-6ACC18BAE3EE Q36075479-72EF96D2-824C-4413-8724-39DE57D98950 Q36161226-37EDB520-63ED-4781-853C-67096869FA1A Q36492332-4656B348-4082-4A95-9368-FC7835A1C1D6 Q36565637-AA03507E-3681-45C4-8C5D-942C9AC28059 Q36577160-336BB0E5-28B9-4773-925B-DFF93D07A806 Q36719691-6C7A6567-79D2-4C33-9621-79664A99A1DF Q36731881-592AFE56-CED6-4784-97CA-052DB68463DC

P2860

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

http://www.wikidata.org/entity/Q35747037

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Immunization with a nontoxic/n ...... d pathology in transgenic mice

@ast

Immunization with a nontoxic/n ...... d pathology in transgenic mice

@en

type

label

Immunization with a nontoxic/n ...... d pathology in transgenic mice

@ast

Immunization with a nontoxic/n ...... d pathology in transgenic mice

@en

prefLabel

Immunization with a nontoxic/n ...... d pathology in transgenic mice

@ast

Immunization with a nontoxic/n ...... d pathology in transgenic mice

@en

P1433

Q35747037-C14642D5-1FFF-4ADA-9FAB-E93AE44E02C3

P1476

Q35747037-92160838-C243-4C06-B61C-5A2F8DD07247

P2093

Q35747037-3429680E-EB19-436B-9E39-009BDE8AEAB7

Q35747037-76E2CC0F-A751-4C72-A6F0-320157187265

Q35747037-FEA758B2-B94A-43BB-8F3E-ABEF6599B47F

P2860

Q35747037-08D9F99E-A6EF-4E04-92B0-32423151F407

Q35747037-0C82089B-0F7F-4F00-B453-940692793A28

Q35747037-18FEBA57-CC3A-4434-B484-F5C0CE0CB8A6

Q35747037-1CEB4B16-680C-4790-80F6-967D57475712

Q35747037-1D0AE6A2-48FB-4C09-8822-274044B92A74

Q35747037-246C54CA-8594-4427-81E7-762DAF121B94

Q35747037-26517B08-9AB6-4FCE-B9F9-2037D7AF697E

Q35747037-2BF7B69F-C6A2-4ABF-B2DC-F9441F824883

Q35747037-2ED61208-80A2-4FF8-8F63-B4B50A55A67C

Q35747037-2F58D1FC-BC0D-47A8-807E-1EE9BAC4A5CF

P304

Q35747037-DA991B43-3C07-4760-B738-DF7C5B14F113

P31

Q35747037-D8E80BBB-C494-4286-8725-2A0AB643833A

P356

Q35747037-864A7F9E-6EAD-418F-B98F-B31E48EAFB16

P407

Q35747037-C7F7EB0F-8074-4EB0-A8E8-44A7CCB91784

P433

Q35747037-D94BA4CF-0F09-4123-965F-40A4D10E283D

P478

Q35747037-392F6E95-89F4-4555-8911-B2EA4B940FB9

P50

Q35747037-5AD45823-EB86-4BCC-875B-FFDCE667F45C

Q35747037-5B0C08B1-39EA-46DC-A3E6-A8BF1FBBF47C

P577

Q35747037-466891EB-EDD4-41DC-85D1-6FC4D1F43427

P698

Q35747037-E9727957-60CA-4C12-814A-FC05E29A1F4C

P921

Q35747037-59624617-5C12-42EF-8A53-507FE79D9345

Q35747037-FCAC3275-1112-4536-9F5C-7DA555ED80A7

P932

Q35747037-925663DF-44E0-41B5-B435-32211A6DCAD3

P356

S0002-9440(10)61715-4

P1433

The American Journal of Pathology

P1476

Immunization with a nontoxic/n ...... d pathology in transgenic mice

@en

P2093

B Frangione

http://www.w3.org/2001/XMLSchema#string

H Scholtzova

http://www.w3.org/2001/XMLSchema#string

P D Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Inflammation and Alzheimer's disease

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias.

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

P304

439-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)61715-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

159

http://www.w3.org/2001/XMLSchema#string

P50

Einar M Sigurdsson

Thomas Wisniewski

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11485902

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1850561

http://www.w3.org/2001/XMLSchema#string